Innate Pharma SA
PAR:IPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innate Pharma SA
PAR:IPH
|
FR |
|
M
|
Map Boga Adiperkasa Tbk PT
IDX:MAPB
|
ID |
|
G
|
Global Environmental Energy Corp
OTC:GEECF
|
BS |
|
Bumrungrad Hospital PCL
SET:BH
|
TH |
|
Red Electrica Corporacion SA
MAD:RED
|
ES |
|
Ardea Resources Ltd
ASX:ARL
|
AU |
|
E
|
Eason & Co PCL
SET:EASON
|
TH |
|
E
|
Eight Capital Partners PLC
F:ECS
|
UK |
|
H
|
Heidelberger Beteiligungsholding AG
XMUN:IPOK
|
DE |
|
Duolingo Inc
NASDAQ:DUOL
|
US |
|
Y
|
Yara International ASA
XMUN:IU2
|
NO |
|
T
|
Thai Mui Corporation PCL
SET:THMUI
|
TH |
|
W
|
WP Energy PCL
SET:WP
|
TH |
|
C
|
Capital Trust Ltd
NSE:CAPTRUST
|
IN |
|
Inca One Gold Corp
XTSX:INCA
|
CA |
|
W
|
Wheels Up Experience Inc
F:2CH
|
US |
|
C
|
Coda Minerals Ltd
ASX:COD
|
AU |
|
Foeroya Banki P/F
CSE:FOBANK
|
FO |
Bankruptcy Probability
Innate Pharma SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Innate Pharma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Innate Pharma SA
PAR:IPH
|
175.8m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Innate Pharma SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Innate Pharma SA has total debt of 13.8m EUR. This includes both short-term (0 EUR) and long-term (13.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
